Patrick Pagesy
Overview
Explore the profile of Patrick Pagesy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ortega-Prieto P, Parlati L, Benhamed F, Regnier M, Cavalcante I, Montabord M, et al.
JHEP Rep
. 2024 Jul;
6(6):101076.
PMID: 38978772
[This corrects the article DOI: 10.1016/j.jhepr.2023.100878.].
2.
Ortega-Prieto P, Parlati L, Benhamed F, Regnier M, Cavalcante I, Montabord M, et al.
JHEP Rep
. 2024 Feb;
6(2):100878.
PMID: 38298740
Background & Aims: -GlcNAcylation is a reversible post-translational modification controlled by the activity of two enzymes, -GlcNAc transferase (OGT) and -GlcNAcase (OGA). In the liver, -GlcNAcylation has emerged as an...
3.
Issad T, Al-Mukh H, Bouaboud A, Pagesy P
J Biomed Sci
. 2022 Sep;
29(1):64.
PMID: 36058931
O-GlcNAcylation corresponds to the addition of N-Acetylglucosamine (GlcNAc) on serine or threonine residues of cytosolic, nuclear and mitochondrial proteins. This reversible modification is catalysed by a unique couple of enzymes,...
4.
Pagesy P, Bouaboud A, Feng Z, Hulin P, Issad T
Cells
. 2022 Jun;
11(11).
PMID: 35681522
O-GlcNAcylation is a reversible post-translational modification involved in the regulation of cytosolic, nuclear, and mitochondrial proteins. Only two enzymes, OGT (O-GlcNAc transferase) and OGA (O-GlcNAcase), control the attachment and removal...
5.
Jimenez-Castillo V, Illescas-Barbosa D, Zenteno E, Avila-Curiel B, Castaneda-Patlan M, Robles-Flores M, et al.
Sci Rep
. 2022 Mar;
12(1):4464.
PMID: 35296731
O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) is a reversible post-translational modification on serine and threonine residues of cytosolic, nuclear and mitochondrial proteins. O-GlcNAcylation level is regulated by OGT (O-GlcNAc transferase), which adds GlcNAc...
6.
Al-Mukh H, Baudoin L, Bouaboud A, Sanchez-Salgado J, Maraqa N, Khair M, et al.
J Immunol
. 2020 Sep;
205(9):2499-2510.
PMID: 32978282
Glycosylation with -linked β--acetylglucosamine (-GlcNAcylation) is a reversible posttranslational modification that regulates the activity of intracellular proteins according to glucose availability and its metabolism through the hexosamine biosynthesis pathway. This...
7.
Filhoulaud G, Benhamed F, Pagesy P, Bonner C, Fardini Y, Ilias A, et al.
Front Endocrinol (Lausanne)
. 2019 Jun;
10:291.
PMID: 31164864
Thioredoxin interacting protein (TxNIP), which strongly responds to glucose, has emerged as a central mediator of glucotoxicity in pancreatic β cells. TxNIP is a scaffold protein interacting with target proteins...
8.
Pagesy P, Tachet C, Mostefa-Kara A, Larger E, Issad T
Exp Clin Endocrinol Diabetes
. 2018 Jun;
127(8):517-523.
PMID: 29890544
O-linked-β-N-Acetylglucosaminylation (O-GlcNAcylation), a reversible post-translational modification involved in diabetic complications, is regulated by only two enzymes, O-linked N-acetylglucosamine transferase (OGT) and β-N-Acetylglucosaminidase (OGA). Increased OGA expression has been described previously...
9.
Marciniak E, Leboucher A, Caron E, Ahmed T, Tailleux A, Dumont J, et al.
J Exp Med
. 2017 Jun;
214(8):2257-2269.
PMID: 28652303
The molecular pathways underlying tau pathology-induced synaptic/cognitive deficits and neurodegeneration are poorly understood. One prevalent hypothesis is that hyperphosphorylation, misfolding, and fibrillization of tau impair synaptic plasticity and cause degeneration....
10.
Pagesy P, Fardini Y, Nguyen T, Lohmann M, Pierre-Eugene C, Tennagels N, et al.
Arch Physiol Biochem
. 2015 Dec;
122(2):54-60.
PMID: 26707268
Context: Insulin analogues are largely used for the treatment of diabetic patients, but concerns have been raised about their mitogenic/anti-apoptotic potential. It is therefore important to evaluate these analogues in...